Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia

Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia

Bibliographic Details
Main Authors: Katarina T. Nguyen, BS, Courtney C. Gwinn, MD, Jay C. Vary, Jr., MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:JAAD Case Reports
Subjects:
autoimmune hemolytic anemia
dermatitis herpetiformis
rituximab
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512619307337

Similar Items

Similar Items